Literature DB >> 26217407

Infertility in a young woman with Type 2 diabetes.

Romana Szaboova1, Senan Devendra2.   

Abstract

KEY MESSAGES: Ovulatory dysfunction is the most common female cause of infertility in the UK.Polycystic ovarian syndrome is associated with oligo-ovulation and Type 2 diabetes.Good glycaemic control is essential before getting pregnant to prevent congenital malformations and miscarriages in young women with Type 2 diabetes.Metformin is safe in the first trimester and reduces the rate of miscarriages and gestational diabetes.Labetalol, methyldopa and hydralazine are deemed safer in pregnancy.Women should not conceive on statins due their potential teratogenic effects. WHY THIS MATTERS TO ME: Polycystic ovarian syndrome (PCOS) is a frequently encountered condition in general practice and can have a significant impact on the quality of life of young women. Apart from addressing ovulatory problems in these women, it is important to remember to screen for other associated conditions such as Type 2 diabetes, hypertension or hypercholesterolaemia. This article outlines the pathophysiology of PCOS and its diagnostic pathways and also summarises the safety of medical management for the metabolic complications in pregnant women. It is important for healthcare professionals to be aware of the latest guidance for treatment of PCOS in order to provide high-standard evidencebased care.

Entities:  

Keywords:  PCOS; hypertension; infertility; type 2 diabetes

Year:  2015        PMID: 26217407      PMCID: PMC4494467          DOI: 10.1080/17571472.2015.11494378

Source DB:  PubMed          Journal:  London J Prim Care (Abingdon)        ISSN: 1757-1472


  6 in total

Review 1.  Glycemic targets for the optimal treatment of GDM.

Authors:  Oded Langer
Journal:  Clin Obstet Gynecol       Date:  2013-12       Impact factor: 2.190

Review 2.  Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis.

Authors:  Cameron Gilbert; Maria Valois; Gideon Koren
Journal:  Fertil Steril       Date:  2006-07-31       Impact factor: 7.329

Review 3.  The use of oral hypoglycaemic agents in pregnancy.

Authors:  R I G Holt; K D Lambert
Journal:  Diabet Med       Date:  2014-03       Impact factor: 4.359

Review 4.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

Review 5.  The effect of antihypertensive drugs on the fetus.

Authors:  T Rosenthal; S Oparil
Journal:  J Hum Hypertens       Date:  2002-05       Impact factor: 3.012

6.  Maternal factors predictive of first‑trimester pregnancy loss in women with pregestational diabetes.

Authors:  Paweł Gutaj; Agnieszka Zawiejska; Ewa Wender-Ożegowska; Jacek Brązert
Journal:  Pol Arch Med Wewn       Date:  2013-01-10
  6 in total
  2 in total

1.  The Impact of Myeloperoxidase and Activated Macrophages on Metaphase II Mouse Oocyte Quality.

Authors:  Faten Shaeib; Sana N Khan; Mili Thakur; Hamid-Reza Kohan-Ghadr; Sascha Drewlo; Ghassan M Saed; Subramaniam Pennathur; Husam M Abu-Soud
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

2.  The Effect of Endometrial Cell Culture on α3 and β1 integrin Genes and Protein Expression in Type 2 Diabetic Rats at The Time of Implantation.

Authors:  Fatemah Sadat Mostafavi; Abbas Bakhteyar; Parvaneh Nikpour; Nahid Eskandari; Roshanak Aboutorabi
Journal:  Cell J       Date:  2022-01       Impact factor: 3.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.